Yangzhou Nanopore Innovative Materials: CSRC Requests Supplementary Materials on Equity Changes Compliance and "Anti-Involution" Policy Alignment
NewTimeSpace News: The International Department of the CSRC has publicly disclosed supplementary material requirements for overseas issuance and listing filings for 24-28 August 2026, under which Yangzhou Nanopore Innovative Materials Technology Co., Ltd. is required to supplement multiple matters.
The requirements include: explaining the pricing basis of historical capital increases and equity transfers, capital contribution compliance and any historical nominee shareholdings; verifying domestic entities behind shareholders holding more than 5% after upward penetration, the progress of the state-owned shareholder identification of Jiantou Investment, and the reasonableness of entry prices of shareholders added within the last 12 months; verifying whether five departed employees retain interests under the employee shareholding plan, with clear conclusions on the plan's compliance and any benefit transfer; explaining whether the business involves overcapacity controlled by the NDRC and MIIT and whether it complies with the national "anti-involution" policy; and stating the expected proceeds after full exercise of the over-allotment option and whether shares of shareholders participating in the "full circulation" are subject to pledges, freezes or other title defects.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TH MEDICAL-B (02697.HK): Signs Sales Contract of Nearly RMB 100 Million for Puncture Surgical Navigation System
- HK shares ETFs Daily Report: Robotics and AI Lead HK ETFs! Hang Seng Biotech ETFs Plunge Over 3.7%, Biomedicine and Blockchain ETFs Collapse - 20260831
- Monthly Shanghai-Shenzhen Stock Connect ETF Average Return Statistics (by Fund Manager) (August 2026)
- Monthly Shanghai-Shenzhen Stock Connect ETF Return Statistics (August 2026)
- Shanghai-Shenzhen Stock Connect ETFs Daily Report: Satellite ETFs Surge Over 4%! STAR AI and Media ETFs Rally Broadly, Gold-Stock and Grain ETFs Slump - 20260831